RECRUITINGOBSERVATIONAL
Studies on Tumors of the Thyroid
Studies on Thyroid Nodules and Thyroid Cancer
About This Trial
Participants in this study will be patients diagnosed with or suspected to have a thyroid nodule or thyroid cancer. The main purpose of this study is to further understand the methods for the diagnosis and treatment of thyroid nodules and thyroid cancer. Many of the test performed are in the context of standard medical care that is offered to all patients with thyroid nodules or thyroid cancer. Other tests are performed for research purposes. In addition, blood and tissue samples will be taken for research and genetic studies.
Who May Be Eligible (Plain English)
* Who May Qualify:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
1. Male or female, adults or children \>= 6 months+.
2. Patients with known or suspected thyroid nodules and/or thyroid cancer.
3. At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.
Who Should NOT Join This Trial:
An individual who meets any of the following criteria will be excluded from participation in this study:
1\. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
* INCLUSION CRITERIA:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
1. Male or female, adults or children \>= 6 months+.
2. Patients with known or suspected thyroid nodules and/or thyroid cancer.
3. At risk family members of patients who have a genetic susceptibility to developing thyroid cancer.
EXCLUSION CRITERIA:
An individual who meets any of the following criteria will be excluded from participation in this study:
1\. Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active coexisting non-thyroid carcinoma requiring intervention before thyroid cancer is addressed.
Treatments Being Tested
DRUG
68-Gallium Dotatate
For evaluation risk/benefit evaluation
Locations (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, United States